Fig. 1From: Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practiceSensitivity analysis for PFS; A: all patients; B: excluding patients not initiating treatment with the recommended dose; C: excluding patients not meeting all the selected PALOMA-2 criteriaBack to article page